Female

19 drugs in development·13 companies·2 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
acitretin	Mylan II B.V. (MYL)
dare to play sildenafil	Dare Bioscience, Inc. (DARE)
norgestimate	Mylan II B.V. (MYL)
supprelin la	Endo LP (NDOI)
tranexamic acid	ANI PHARMACEUTICALS INC (ANIP)
Xaciato	Organon & Co. (OGN)

Phase 3(1)

Drug	Company
Bupivacaine Injection [Marcaine]	COGNITION THERAPEUTICS INC (CGTX)

Phase 2(4)

Drug	Company
Estradiol	ENANTA PHARMACEUTICALS INC (ENTA)
MVT-602	Myovant Sciences Ltd. (MYOV)
Sildenafil Cream, 3.6%	Dare Bioscience, Inc. (DARE)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)

Phase 1(1)

Drug	Company
EDP167	Cidara Therapeutics, Inc. (CDTX)

Unknown(3)

Drug	Company
Ainos Flora (VOC POCT)	Ainos Inc. (AIMD)
al-101	Oncotelic Therapeutics, Inc. (OTLC)
FemCelz®	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

N/A(3)

Drug	Company
Clomiphene Citrate.	ENANTA PHARMACEUTICALS INC (ENTA)
Guaifenesin	ENANTA PHARMACEUTICALS INC (ENTA)
OvaStem™	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Phase 4(1)

Drug	Company
Dexmedetomidine Injection [Precedex]	COGNITION THERAPEUTICS INC (CGTX)

BioSniper tracks 19 drugs in development for Female across 13 companies.

There are 2 clinical trials targeting Female tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.